These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 34524426)

  • 1. Learning event tackles needs of community pharmacy, ambulatory care.
    Am J Health Syst Pharm; 2021 Nov; 78(22):2013-2014. PubMed ID: 34524426
    [No Abstract]   [Full Text] [Related]  

  • 2. Community and ambulatory pharmacy: evaluation of patient care services and billing patterns before implementation of Medicare part D.
    Beatty SJ; Rodis JL; Bellebaum KL; Mehta BH
    J Am Pharm Assoc (2003); 2006; 46(6):707-14. PubMed ID: 17176686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of pharmaceutical services in community and ambulatory care settings: evidence and recommendations for future research.
    Singhal PK; Raisch DW; Gupchup GV
    Ann Pharmacother; 1999 Dec; 33(12):1336-55. PubMed ID: 10630834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical care in community pharmacies: practice and research in Estonia.
    Volmer D; Vendla K; Vetka A; Bell JS; Hamilton D
    Ann Pharmacother; 2008 Jul; 42(7):1104-11. PubMed ID: 18577761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Market dynamics of community pharmacies in Minnesota, U.S. from 1992 through 2012.
    Schommer JC; Yusuf AA; Hadsall RS
    Res Social Adm Pharm; 2014; 10(1):217-31. PubMed ID: 23669250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Projection of future pharmacy service fees using the dispensing claims in hospital and clinic outpatient pharmacies: national health insurance database between 2006 and 2012.
    Ha D; Song I; Lee EK; Shin JY
    BMC Health Serv Res; 2018 May; 18(1):327. PubMed ID: 29724220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining and characterising age-friendly community pharmacies: a qualitative study.
    Malet-Larrea A; Arbillaga L; Gastelurrutia MÁ; Larrañaga B; Garay Á; Benrimoj SI; Oñatibia-Astibia A; Goyenechea E
    Int J Pharm Pract; 2019 Feb; 27(1):25-33. PubMed ID: 29693292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs of implementing pharmaceutical care in community pharmacies.
    Norwood GJ; Sleath BL; Caiola SM; Lien T
    J Am Pharm Assoc (Wash); 1998; 38(6):755-61. PubMed ID: 9861794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges of standardized continuous quality improvement programs in community pharmacies: the case of SafetyNET-Rx.
    Boyle TA; MacKinnon NJ; Mahaffey T; Duggan K; Dow N
    Res Social Adm Pharm; 2012; 8(6):499-508. PubMed ID: 22421196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of current operations and future plans for ambulatory pharmacy services.
    Powell MF; Stevenson JD; Solomon DK
    Top Hosp Pharm Manage; 1991 Jul; 11(2):79-89. PubMed ID: 10128639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The availability of pharmacies in the United States: 2007-2015.
    Qato DM; Zenk S; Wilder J; Harrington R; Gaskin D; Alexander GC
    PLoS One; 2017; 12(8):e0183172. PubMed ID: 28813473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Providing patient care through community pharmacies in the UK: policy, practice, and research.
    Noyce PR
    Ann Pharmacother; 2007 May; 41(5):861-8. PubMed ID: 17456540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apocalypse Now?
    Rupp MT
    Ann Pharmacother; 2017 Oct; 51(10):921-922. PubMed ID: 28608718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A qualitative case study exploring the implementation of pharmacist care planning services in community pharmacies.
    Hughes CA; Breault RR; Schindel TJ
    J Am Pharm Assoc (2003); 2020; 60(4):580-588.e2. PubMed ID: 31953119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost analysis of a novel HIV testing strategy in community pharmacies and retail clinics.
    Lecher SL; Shrestha RK; Botts LW; Alvarez J; Moore JH; Thomas V; Weidle PJ
    J Am Pharm Assoc (2003); 2015; 55(5):488-92. PubMed ID: 26359959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent community pharmacies' provision of enhanced services: A mixed methods approach.
    Facciolo F; Siracuse MV; Galt KA; Fuji KT; Bramble JD
    J Am Pharm Assoc (2003); 2021; 61(6):819-828.e1. PubMed ID: 34332888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of network ties to support implementation of a community pharmacy enhanced services network.
    Turner K; Weinberger M; Renfro C; Ferreri S; Trygstad T; Trogdon J; Shea CM
    Res Social Adm Pharm; 2019 Sep; 15(9):1118-1125. PubMed ID: 30291004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A state-level needs analysis of community pharmacy point-of-care testing.
    Gallimore CE; Porter AL; Barnett SG; Portillo E; Zorek JA
    J Am Pharm Assoc (2003); 2021; 61(3):e93-e98. PubMed ID: 33431252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive counselling for public health in pharmacies in South Germany.
    Schmiedel K; Schlager H; Dörje F
    Int J Clin Pharm; 2013 Feb; 35(1):138-44. PubMed ID: 23129420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community pharmacists' opinions and practice of pharmaceutical care at chain pharmacy and independent pharmacy in China.
    Xi X; Huang Y; Lu Q; Ung COL; Hu H
    Int J Clin Pharm; 2019 Apr; 41(2):478-487. PubMed ID: 30864081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.